Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Human exosomes are effective for targeted treatments but face scalability issues, while plant exosomes are cost-effective for cosmetics.

Licorice can effectively treat stomach ulcers and may work as well as or better than some standard drugs.

Post-COVID-19 hair loss can be treated effectively with therapies like light therapy, microneedling, and scalp massage.

Selenium is essential for health, but too little or too much can cause serious health problems.

Survivors of severe COVID-19 need ongoing care to manage lasting health issues.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Pilomatrixoma should be considered for nodular lesions in adults.

Long-COVID has diverse, long-term health impacts, especially in young people.

Quality of life improved after COVID-19, but ongoing health support is needed.

COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.

Some children with COVID-19 develop skin symptoms linked to a severe inflammatory condition.

No single biomarker is reliable enough for diagnosing and assessing SLE.

The May 2021 issue of the Journal of Cosmetic Dermatology suggests injectables are becoming more reliable and may reduce the need for cosmetic surgery.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Understanding alopecia in Mexican adults helps create better, tailored treatments.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Cepharanthine shows promise as a COVID-19 treatment.

The pandemic changed the types of skin conditions seen, not the number of visits.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.